In Vitro Diagnostics Market Future Challenges and Industry Growth Outlook 2030 Global In Vitro Diagnostics Market Report offers in-depth analysis of the market size, share, major segments, and different geographic regions, forecast for the next five years, key market players, and premium industry trends. It also focuses on the key drivers, restraints, opportunities and challenges. Browse key industry insights spread across 196 pages with 239 market data tables & 18 figures & charts from the report, “In-vitro Diagnostics Market Analysis By Product Type (Reagents & Kits, Instruments), Test Type (Clinical Chemistry, Immunoassay/Immunochemistry, Molecular Diagnostics, Hematology, Urinalysis), Application (Oncology, Infectious Diseases, Diabetes, Cardiology, Nephrology, Autoimmune Diseases, Drug Testing/Pharmacogenomics), End-user (Hospitals, Diagnostic Laboratories, Academic & Research Institutes), Industry Analysis Report, Regional Outlook, Growth Potential, Competitive Market Share & Forecast, 2022 - 2030” in detail along with the table of contents: https://www.gminsights.com/industry-analysis/in-vitro-diagnostics-market During the COVID-19 pandemic, the industry witnessed a positive impact due to the rise in demand for diagnostic testing solutions as well as continuous R&D activities in the field. Furthermore, government organizations like the U.S. Food & Drug Administration (FDA) have actively taken part in promoting the usage of various in vitro diagnostics tests, which aided business growth. Moreover, major participants in the industry have been focusing on investing in research activities and advancements in in-vitro diagnostics tests to gain a better foothold in the market. For instance, in May 2022, Siemens Healthineers, a leading diagnostics solutions company, implemented the In-Vitro Diagnostic Device Regulation (IDVR) certification in its product portfolio, becoming the first company to ever implement IDVR certification. The in-vitro diagnostics market has been bifurcated on the basis of application, product type, test type, end-user, and region. In terms of product type, the in-vitro diagnostics industry has been split into instruments and reagents & kits. The instruments segment was valued at more than $29.5 billion in 2021 as a result of growing number of pathology laboratories and centers with advanced diagnostics machines. With reference to test type, the market has been categorized into urinalysis, clinical chemistry, hematology, immunoassay/immunochemistry, molecular diagnostics, and others. Among these, the clinical chemistry segment held around 18.1% market share in 2021 attributed to rising adoption of clinical chemistry analyzers to diagnose and monitor a range of diseases, such as diabetes, cancer, cardiac disease, kidney illnesses, and liver diseases.
© 2022 All Rights Reserved
www.gminsights.com